Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-16

FDA Approved: ETHOSUXIMIDE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for Ethosuximide filed by Epic Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethosuximide (ethosuximide)

Snippet

SUPPL AP for ETHOSUXIMIDE (ETHOSUXIMIDE)